SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables

CHINO HILLS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced:

SOHM OTC Self-care launches a suite of 13 new SOHM Nutrients’ Brand Chewables.

SOHM OTC Self-care business unit is launching its suite of 13 new SOHM Nutrients’ Brand Chewables into the global vitamin gummies market.

The global vitamins market is valued at $6.84 billion in 2022 and is expected to reach $18.76 billion by 2031 with a CAGR of 12.06% between 2023-2031. (CAGR, Compounded Annual Growth Rate.)

Source:  Link to Insight ACE Analytics report 2022

Research and Markets report noted the drivers for the explosive growth of the global vitamin gummies include:

-- Global consumers gaining wealth and spending more on healthcare, self-care products
-- Health benefits (vitamins, minerals)
-- Taste (fruit flavors)
-- Convenience (pocket portability)
-- Access (no water needed)

The suite of these 13 SOHM Nutrients’ Brand Chewables will be offering consumers these key features:

-- Bone health, skin health, immune boost, mineral replenishment, and sleep aid
-- Convenience of individually wrapped single serving (pocket friendly)
-- Chewables (no water required)
-- Taste (mango, strawberry, pineapple, toffee)

These SOHM Nutrients’ Brand Chewables also boast the same sought-after ingredients and labels as the leading vitamin gummies on Amazon.com:

-- Turmeric, folic acid, multi-vitamins, multi-minerals
-- Nuts free
-- Gluten free
-- Gelatin free
-- Vegan
-- Soy free

“This launch of our suite of SOHM Nutrients’ Brand Chewables marks our commitment to continually building out a strong SOHM ‘Adds Life to Lives’ portfolio of products in preventive care segments. Going into 2024, we will be announcing additional OTC Self-care products launches to include our in-house manufactured products from the labs and production lines of our CDMO facilities located in San Diego, California. This launch will have an appreciable impact on our sales going forth,” says Dr. David Aguilar, PhD, COO of SOHM.